Free shipping on orders over $99
Need it for Christmas?
Living with Hereditary Cancer Risk

Living with Hereditary Cancer Risk

What You and Your Family Need to Know

by Kathy SteligoSue Friedman and Allison W. Kurian
Hardback
Publication Date: 26/12/2022

Share This Book:

16%
OFF
RRP  $111.00

RRP means 'Recommended Retail Price' and is the price our supplier recommends to retailers that the product be offered for sale. It does not necessarily mean the product has been offered or sold at the RRP by us or anyone else.

$93.50
or 4 easy payments of $23.37 with
afterpay
This item qualifies your order for FREE DELIVERY

The most comprehensive guide available on hereditary cancers, from understanding risk, prevention, and genetic counseling and testing to treatment, quality of life, and more.

Up to 10 percent of cancers are caused by inherited mutations in specific genes. Finding out that you or your loved ones may be at increased risk of developing cancer because of a genetic mutation raises a lot of questions: Is cancer inevitable? Is there anything I should do differently in my life? Will my children also be at higher risk of cancer? Should I have preemptive treatments or surgery? This comprehensive guide provides answers to these questions and more.

Written by three passionate patient advocates, this book is a compilation of the trusted information and support provided for more than two decades by Facing Our Risk of Cancer Empowered (FORCE), the de facto voice of the hereditary cancer community. Combining the latest scientific research with national guidelines, expert advice, and compelling patient stories, the book offers previvors (those who have a mutation but have never been diagnosed), survivors, and their families the guidance they need to face the unique physical and emotional challenges of living in a high-risk body.

An ideal resource for genetic counselors, physicians, nurses, advocates, and others who support and care for the hereditary cancer community, Living with Hereditary Cancer Risk also provides coverage of

- signs of inherited cancer risk in a family;
- the value of genetic counseling and testing;
- mutations in BRCA, Lynch Syndrome, and other genes that elevate cancer risk;
- risk-reducing strategies;
- traditional treatments and newer personalized approaches, including immunotherapies and PARP inhibitors;
- nationally recommended guidelines for prevention, early detection, and treatment;
- insurance coverage and discrimination protections; and
- coping with sexual health, fertility, menopause, and other quality of life issues.

ISBN:
9781421444253
9781421444253
Category:
Clinical & internal medicine
Format:
Hardback
Publication Date:
26-12-2022
Language:
English
Publisher:
Johns Hopkins University Press
Country of origin:
United States
Dimensions (mm):
236.22x160.02x33.02mm
Weight:
0.93kg
Kathy Steligo

Freelance writer Kathy Steligo (SAN CARLOS, CA), a two-time breast cancer survivor, is the author of The Breast Reconstruction Guidebook and the coauthor of Confronting Chronic Pain and Confronting Hereditary Breast and Ovarian Cancer.

This title is in stock with our Australian supplier and should arrive at our Sydney warehouse within 1 - 2 weeks of you placing an order.

Once received into our warehouse we will despatch it to you with a Shipping Notification which includes online tracking.

Please check the estimated delivery times below for your region, for after your order is despatched from our warehouse:

ACT Metro: 2 working days
NSW Metro: 2 working days
NSW Rural: 2-3 working days
NSW Remote: 2-5 working days
NT Metro: 3-6 working days
NT Remote: 4-10 working days
QLD Metro: 2-4 working days
QLD Rural: 2-5 working days
QLD Remote: 2-7 working days
SA Metro: 2-5 working days
SA Rural: 3-6 working days
SA Remote: 3-7 working days
TAS Metro: 3-6 working days
TAS Rural: 3-6 working days
VIC Metro: 2-3 working days
VIC Rural: 2-4 working days
VIC Remote: 2-5 working days
WA Metro: 3-6 working days
WA Rural: 4-8 working days
WA Remote: 4-12 working days

Reviews

Be the first to review Living with Hereditary Cancer Risk.